Pablo Cabral

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 4

Top Topics

Oxide Nanoparticles

Metastatic Colorectal Cancer

Vascular Endothelial Growth Factor

Top Venues

Chemistry (Weinheim an der Bergstrasse, Germany)

Pharmaceuticals (Basel, Switzerland)

Anti-cancer agents in medicinal chemistry

Universidad de la República Uruguay

Universidad de la República Uruguay (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universidad de la República Uruguay

Uruguay

Profesor Adjunto de Radiofarmacia :: Facultad de Ciencias

Education History

Universidad de la República Uruguay

Uruguay

PHD :: PEDECIBA - Facultad de Quimica

Universidad de la República Uruguay

Uruguay

MSC :: Facultad de Quimica

Publications

Ximena Camacho, Carolina Perroni, Lucía Alfaya, Mirel Cabrera, Marcos Tassano, María Fernanda García, Marcelo Fernández, Ana Laura Reyes, Andrea Paolino, Eduardo Savio, Hugo E Cerecetto, Pablo Cabral, Juan Pablo Gambini
Molecular Imaging of Melanoma VEGF-expressing Tumors through [99mTc]Tc-HYNIC-Fab(Bevacizumab). Anti-cancer agents in medicinal chemistry (2024)
Nicole Lecot, Belén Dávila, Carina Sánchez, Marcelo Fernández, Mercedes González, Pablo Cabral, Hugo E Cerecetto, Romina J Glisoni
Development and Evaluation of 2-Amino-7-Fluorophenazine 5,10-Dioxide Polymeric Micelles as Antitumoral Agents for 4T1 Breast Cancer. Polymers 14 (1) (2021)
Romina Castelli, Manuel Ibarra, Ricardo Faccio, Iris Miraballes, Marcelo Fernández, Albertina G Moglioni, Pablo Cabral, Hugo Cerecetto, Romina J Glisoni, Victoria Calzada
T908 Polymeric Micelles Improved the Uptake of Sgc8-c Aptamer Probe in Tumor-Bearing Mice: A Co-Association Study between the Probe and Preformed Nanostructures. Pharmaceuticals (Basel, Switzerland) 15 (1) (2021)
Marcos Couto, María Fernanda García, Catalina Alamón, Mauricio Cabrera, Pablo Cabral, Alicia Merlino, Francesc Teixidor, Hugo E Cerecetto, Clara Viňas
Discovery of Potent EGFR Inhibitors through the Incorporation of a 3D-Aromatic-Boron-Rich-Cluster into the 4-Anilinoquinazoline Scaffold: Potential Drugs for Glioma Treatment. Chemistry (Weinheim an der Bergstrasse, Germany) 24 (13) (2017)